Vistara Growth invests in venture-backed meQuilibrium

Vistara Growth has invested in meQuilibrium, a Boston-based digital resilience solution for organizations to address the wellbeing of their employees.

Vistara Growth has invested in meQuilibrium, a Boston-based digital resilience solution for organizations to address burnout, stress, purpose, performance and the wellbeing of their employees. No financial terms were disclosed. Investors in meQuilibrium include Chrysalis Ventures and HLM Venture Partners. Vistara is a Canadian provider of growth debt and equity solutions to technology companies.

PRESS RELEASE

Vistara Growth announced today its investment in meQuilibrium, the leading digital resilience solution for organizations to holistically address burnout, stress, purpose, performance, and the wellbeing of their employees.

At this time when companies are struggling to retain and hire staff, the need for a resilient workforce is more imperative than ever. Vistara’s investment helps meQuilibrium better address the needs of more Fortune 500 companies by expediting the execution of its innovative product roadmap, pursuing acquisitions of complementary technologies, and launching new go-to-market initiatives. Company revenues have experienced a 3-year compound annual growth rate (CAGR) of more than 50%.

Proactively Building Workforce Wellness and Resilience
“There are a number of HR technology companies that are trying to address workforce mental health and wellbeing; meQuilibrium’s scientific and data driven approach to curriculum creation and delivery provides a proven solution for empowering employees and mitigating behavioral health risks,” said Kathleen Kaulins, Director, Investments at Vistara Growth. “Our goal is to help the company quickly bring in additional talent to meet increasing customer demand and further innovate its offering.”

Many employees are feeling burned out and anxious due to the demands of an increasingly complex and connected work environment exacerbated by the disruption and uncertainty of the ongoing COVID-19 pandemic. Many companies are now prioritizing employee wellbeing and focused on building a more resilient workforce. meQuilibrium offers organizations a proven solution designed to help reduce employee turnover and increase productivity.

“While most employee assistance programs are reactive, meQuilibrium’s solution proactively helps employees develop the skills to prevent burnout,” said Noah Shipman, Partner at Vistara Growth. “Rather than generic content or reactive crisis management offerings, meQuilibrium’s highly personalized offerings drive strong engagement among employee users making it the platform of choice for businesses that are serious about investing in employee wellbeing and resilience. We’re excited to help bring this innovative platform to more people.”

“We are excited to partner with Vistara to fuel meQuilibrium’s growth in 2022 and beyond. With workforce wellbeing and performance top of mind for employers during a time of record turnover and continued disruption, meQuilibrium is poised to support a larger and more diverse global customer base with an expanded team and new solutions.” – Jan Bruce, CEO and Co-Founder, meQuilibrium

meQuilibrium has been recently and consistently recognized for its growth and innovation through inclusion on the Financial Times 2021 Fastest Growing Companies, the Inc. 5000 list in 2021, 2020, 2019, Deloitte Fast 500 Technology Awards in 2021, 2020, 2019, SaaS Award Best Product in HR 2021, and the 2021 MassTLC Tech Top 50. In addition, meQuilibrium has earned a customer NPS rating of 73 (June 2021).

For further details on Vistara’s investment thesis, read Why We Invested in meQuilibrium.

About meQuilibrium
meQuilibrium is the #1 digital solution for building employee resilience at scale for Fortune 500 global enterprises, helping businesses innovate and navigate uncertain times. meQuilibrium harnesses the science of resilience, AI, predictive analytics, biometrics and neuroscience to help businesses build workforce wellbeing and potential. Learn more at meQuilibrium.com.